These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2692413)

  • 1. Measurement of des-Phe8-Arg9-bradykinin by enzyme-immunoassay--a useful parameter of plasma kinin release.
    Majima M; Ueno A; Sunahara N; Katori M
    Adv Exp Med Biol; 1989; 247B():331-5. PubMed ID: 2692413
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolism of bradykinin agonists and antagonists by plasma aminopeptidase P.
    Ward PE; Chow A; Drapeau G
    Biochem Pharmacol; 1991 Jul; 42(4):721-7. PubMed ID: 1651078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in the kinin levels in the bronchial washings after intravenous injection of leukotriene C4 in guinea pigs.
    Majima M; Jin HY; Katori M; Sunahara N
    Agents Actions Suppl; 1992; 38 ( Pt 3)():467-74. PubMed ID: 1462880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of combined neutral endopeptidase 24-11 and angiotensin-converting enzyme inhibition on femoral vascular conductance in streptozotocin-induced diabetic rats.
    Arbin V; Claperon N; Fournié-Zaluski MC; Roques BP; Peyroux J
    Br J Pharmacol; 2000 Jul; 130(6):1297-304. PubMed ID: 10903969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contributions of various rat plasma peptidases to kinin hydrolysis.
    Ishida H; Scicli AG; Carretero OA
    J Pharmacol Exp Ther; 1989 Dec; 251(3):817-20. PubMed ID: 2557417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of digoxigenin-labeled peptide: application to chemiluminoenzyme immunoassay of bradykinin in inflamed tissues.
    Décarie A; Drapeau G; Closset J; Couture R; Adam A
    Peptides; 1994; 15(3):511-8. PubMed ID: 7937327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of bradykinin by angiotensin-converting enzyme and by carboxypeptidase N in human plasma.
    Kuoppala A; Lindstedt KA; Saarinen J; Kovanen PT; Kokkonen JO
    Am J Physiol Heart Circ Physiol; 2000 Apr; 278(4):H1069-74. PubMed ID: 10749699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum interspecies differences in metabolic pathways of bradykinin and [des-Arg9]BK: influence of enalaprilat.
    Décarie A; Raymond P; Gervais N; Couture R; Adam A
    Am J Physiol; 1996 Oct; 271(4 Pt 2):H1340-7. PubMed ID: 8897926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Responses of the kallikrein-kinin system to angiotensin converting enzyme inhibitors in the rat.
    Yasujima M; Abe K; Tanno M; Omata K; Yoshinaga K
    Jpn Circ J; 1984 Feb; 48(2):173-9. PubMed ID: 6321815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme-linked immunosorbent assays for kinins using high-affinity monoclonal kinin antibodies.
    Odya CE; Lee CH
    Biochem Pharmacol; 1990 Jul; 40(2):245-51. PubMed ID: 2375767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does insulin release kinins in rats?
    Damas J; Garbacki N; Lefèbvre PJ
    Eur J Pharmacol; 2005 Nov; 525(1-3):154-60. PubMed ID: 16297383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of renal endopeptidase 24.11 in kinin metabolism in vitro and in vivo.
    Ura N; Carretero OA; Erdös EG
    Kidney Int; 1987 Oct; 32(4):507-13. PubMed ID: 2828746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of angiotensin converting enzyme inhibitors MK 421, SA 446 and captopril on renal prostaglandin E and kinins in conscious normotensive rats.
    Yasujima M; Abe K; Tanno M; Kohzuki M; Kasai Y; Kanazawa M; Omata K; Sato M; Takeuchi K; Yoshinaga K
    Clin Exp Hypertens A; 1987; 9(2-3):401-4. PubMed ID: 3038402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of endogenous bradykinins in the acute depressor effect of angiotensin converting enzyme inhibitor captopril--assessed by a competitive antagonist of bradykinin.
    Seino M; Abe K; Nushiro N; Omata K; Yoshinaga K
    Clin Exp Hypertens A; 1989; 11(1):35-43. PubMed ID: 2653669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypotensive reaction during staphylococcal protein A column therapy in a patient with anomalous degradation of bradykinin and Des-Arg9-bradykinin after contact activation.
    Molinaro G; Adam A; Lepage Y; Hammerschmidt D; Koenigbauer U; Eastlund T
    Transfusion; 2002 Nov; 42(11):1458-65. PubMed ID: 12421219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggregate anaphylaxis and carboxypeptidase N.
    Ryan JW; Berryer P; Hart MA; Ryan US
    Adv Exp Med Biol; 1986; 198 Pt A():435-43. PubMed ID: 3028062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of bradykinin effect by angiotensin-converting enzyme inhibition does not correlate with angiotensin-converting enzyme activity in the rat mesenteric arteries.
    Sivieri DO; Bispo-da-Silva LB; Oliveira EB; Resende AC; Salgado MC
    Hypertension; 2007 Jul; 50(1):110-5. PubMed ID: 17470724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoassays for des-Arg9-bradykinin.
    Odya CE; Carlin RJ; Yapa RD; Soltani-Tehrani B
    J Immunoassay; 1993 Dec; 14(4):227-40. PubMed ID: 8294567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of angiotensin-converting enzyme inhibitors on the vascular response to norepinephrine.
    Saruta T; Suzuki H; Okuno T; Kondo K
    Am J Cardiol; 1982 Apr; 49(6):1535-6. PubMed ID: 6176110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of bradykinin generating and degrading systems in the vascular permeability response induced with kaolin in rats.
    Kumakura S; Kamo I; Tsurufuji S
    Adv Exp Med Biol; 1989; 247B():541-6. PubMed ID: 2610091
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.